Publication:
Evaluation of the knowledge, attitude, and behaviors of physicians and pharmacists regarding the use of medicines in pregnancy

dc.contributor.coauthorTamirci, Mevhibe
dc.contributor.coauthorAkıcı, Ahmet
dc.contributor.coauthorAydın, Volkan
dc.contributor.coauthorGören, Mehmet Zafer
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorSakarya, Sibel
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T12:02:43Z
dc.date.issued2021
dc.description.abstractPregnancy is a critical aspect of rational use of medicine (RUM) and imposes important responsibilities on the parties. This study aimed to analyze the knowledge, attitudes, and behaviors of the physicians and pharmacists regarding pharmacotherapy in pregnancy. The data were collected between April 2016-July 2017 by questionnaires and analyses of the prescriptions in Northern Cyprus. Simulated prescriptions (n=50) for pregnant women (PW) were applied at pharmacies, and pharmacists' (n=95) and obstetricians' (n=30) attitudes were evaluated through surveys. In addition, PW prescriptions (n=122) were collected from pharmacies and evaluated. All data were re-obtained after one year. The mean number of drugs per PW prescription was 1.48 +/- 0.73. In teratogenicity risk evaluation, 6.6% of medicines were in "D/X" and 16.7% were in "C" categories. The ratio of these three categories medicines in scripts was about eight times higher than which was considered as teratogenic based on physicians' opinions. Serious shortcomings were found in writing the format information in prescriptions. In simulated prescription analysis, mean dispensing time was 3.3 +/- 2.3 min. Almost half of the pharmacists were observed to give the drug requested by simulated PW without any confirmation of the prescription. The dispensing performances of the pharmacists were mainly different than their related statements on the survey. Our study highlighted the deficiencies in physicians' and pharmacists' RUM knowledge, attitudes, and behaviors in pregnancy, where the gaps seem unchanged after one year. These findings underline necessity of education and counselling service interventions for healthcare providers to disseminate RUM in pregnancy.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume25
dc.identifier.doi10.29228/jrp.12
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02830
dc.identifier.issn2630-6344
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85103511409
dc.identifier.urihttps://doi.org/10.29228/jrp.12
dc.identifier.wos629451200012
dc.keywordsPharmacist
dc.keywordsPregnancy
dc.keywordsPrescriber
dc.keywordsPrescription simulation
dc.keywordsTeratogenicity
dc.language.isoeng
dc.publisherMarmara University Press
dc.relation.grantnoNA
dc.relation.ispartofJournal of Research in Pharmacy
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9481
dc.subjectPharmacology and pharmacy
dc.titleEvaluation of the knowledge, attitude, and behaviors of physicians and pharmacists regarding the use of medicines in pregnancy
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorSakarya, Sibel
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
9481.pdf
Size:
910.37 KB
Format:
Adobe Portable Document Format